Sort
46,585 grants matching “heart failure”
Functional and Biological Phenotyping of Pediatric PH
$547,287Robin Shandas · University Of Colorado Denver · R01 · FY2016 · HL
CAREER: Virtual communities of learning and care: multi-user virtual environments that promote positive youth development
$547,250Marina Bers · Tufts University · · FY2005 · CSE
Novel Strategy of PDE5-mTOR Inhibition in Attenuation of Cancer Drug Cardiotoxicity
$547,243Rakesh C. Kukreja · Virginia Commonwealth University · R01 · FY2023 · HL
Cardiovascular health and exposure to PM2.5 constituents: a multi-cohort study
$547,223Yang Liu · Emory University · R01 · FY2021 · ES
Mitochondrial Dysfunction Underlies the Integrated Stress Response Activation in Ponatinib-Induced Cardiotoxicity
$547,212Won Hee Lee · University Of Arizona · R01 · FY2023 · HL
Calcium-phosphorus metabolism and the risk of cardiovascular disease
$547,187Eric N Taylor · Brigham And Women'S Hospital · R01 · FY2011 · HL
Endothelial Progenitor Cells: Clinical Correlates and Prognosis in the Community
$547,173Thomas J Wang · Massachusetts General Hospital · R01 · FY2008 · HL
Understanding the molecular mechanism of cardiomyocyte dedifferentiation and proliferation during regeneration
$547,171Michael Waikok Tsang · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
The Effects of Interleukin-1 Blockade On Exercise Capacity In Patients With Recently Decompensated Systolic Heart Failure
$547,121Benjamin W Van Tassell · Virginia Commonwealth University · R33 · FY2019 · HL
The Effects of Interleukin-1 Blockade On Exercise Capacity In Patients With Recently Decompensated Systolic Heart Failure
$547,121Benjamin W Van Tassell · Virginia Commonwealth University · R33 · FY2020 · HL
Cardiac microlesion formation during invasive pneumococcal disease
$547,115Carlos J Orihuela · University Of Alabama At Birmingham · R01 · FY2025 · AI
Effect of Statins and Modifiable Factors on Stroke Outcome in Atrial Fibrillation
$547,070Elaine Hylek · Boston Medical Center · R01 · FY2010 · NS
Optimization of small molecule integrin activators to enhance cord blood transplant
$547,028Peter Vanderslice · Texas Heart Institute · R33 · FY2022 · HL
Optimization of small molecule integrin activators to enhance cord blood transplant
$547,028Peter Vanderslice · Texas Heart Institute · R33 · FY2023 · HL
Assessing Tyrosine Kinase Inhibitors-induced Cardiotoxicity with an Organoid-AI System
$547,020Huaxiao Yang · University Of North Texas · R56 · FY2024 · HL
Hydrogen Sulfide Regulation in Cardioprotection
$547,018Ming Xian · Brown University · R01 · FY2023 · HL
Protein Kinase Novel 2 (PKN2) in heart
$546,998Ju Chen · University Of California, San Diego · R01 · FY2022 · HL
An expandable polymeric valved conduit to repair congenital heart disease
$546,993Giovanni Ferrari · Columbia University Health Sciences · R01 · FY2025 · HL
Preconceptual Bisphenol and Phthalate Effects on Early Embryonic Development
$546,907Leonardo Trasande · New York University School Of Medicine · R01 · FY2022 · ES
Lens β-Amyloid Biomarker for Early Detection of Preclinical Alzheimer's Disease in the Framingham Study
$546,892Lee E Goldstein · Boston University Medical Campus · R01 · FY2025 · AG
Mechanism-inspired Strategies to Prevent Pathogenic Late Na Current in Cardiac Arrhythmias
$546,855Manu Ben Johny · Columbia University Health Sciences · R01 · FY2024 · HL
Glucolipotoxicity and Cardiac Dysfunction in Obesity
$546,842University Of Texas Hlth Sci Ctr Houston · R01 · FY2004 · HL
Viral subversion of intercellular coupling during myocarditis
$546,830James William Smyth · Virginia Polytechnic Inst And St Univ · R01 · FY2022 · HL
PPAR-gamma Deacetylation in Cardiometabolic Disease
$546,810Domenico Accili · Columbia University Health Sciences · P01 · FY2019 · HL
PPAR-gamma Deacetylation in Cardiometabolic Disease
$546,810Domenico Accili · Columbia University Health Sciences · P01 · FY2020 · HL